TM4SF5 and malignant colon neoplasm: Furthermore, we produced a monoclonal antibody that specifically recognizes human and mouse TM4SF5 and confirmed that the anti-TM4SF5 monoclonal antibody has a therapeutic effect in mouse models for HCC and colon cancer [14, 15].